BG Medicine, Inc. - FORM 10-K - EX-32.1 - CERTIFICATION OF THE CEO AND CFO PURSUANT TO SECTION 906 - March 30, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BG Medicine, Inc.Financial_Report.xls
EX-23.1 - CONSENT OF DELOITTE & TOUCHE LLP - BG Medicine, Inc.d262852dex231.htm
EX-31.2 - CERTIFICATION OF THE CFO PURSUANT TO SECTION 302 - BG Medicine, Inc.d262852dex312.htm
EX-10.33 - NON-QUALIFIED STOCK OPTION AGREEMENT - BG Medicine, Inc.d262852dex1033.htm
EX-10.22 - EMPLOYMENT AGREEMENT BY AND BETWEEN THE REGISTRANT AND PIETER MUNTENDAM - BG Medicine, Inc.d262852dex1022.htm
EX-10.21 - EMPLOYMENT AGREEMENT BY AND BETWEEN THE REGISTRANT AND ERIC BOUVIER - BG Medicine, Inc.d262852dex1021.htm
EX-10.36 - NON-EMPLOYEE DIRECTOR COMPENSATION POLICY - BG Medicine, Inc.d262852dex1036.htm
EX-10.11.2 - AMENDMENT TO THE PARTICIPATION AGREEMENT - BG Medicine, Inc.d262852dex10112.htm
EX-10.12.2 - AMENDMENT TO THE PARTICIPATION AGREEMENT - BG Medicine, Inc.d262852dex10122.htm
EX-10.14.2 - AMENDMENT TO THE PARTICIPATION AGREEMENT - BG Medicine, Inc.d262852dex10142.htm
10-K - FORM 10-K - BG Medicine, Inc.d262852d10k.htm
EX-31.1 - CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 - BG Medicine, Inc.d262852dex311.htm

Exhibit 32.1

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of BG Medicine, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report for the year ended December 31, 2011 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 30, 2012  

/s/ Eric Bouvier

 

Eric Bouvier

President and Chief Executive Officer

(principal executive officer)

Dated: March 30, 2012  

/s/ Michael W. Rogers

 

Michael W. Rogers

Executive Vice President, Chief Financial Officer and

Treasurer (principal financial officer)

BG Medicine, Inc. Reports